BEAMSTART Logo

VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead

e27 Logoe2713h ago

VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead - e27

Quick Summary:

Unlike conventional methods, which directly attack cancer cells, immunotherapy harnesses the body’s own immune system to combat the disease.

Traditionally, cancer treatment has relied on aggressive methods such as surgery, radiation, and chemotherapy.

However, a new paradigm has emerged with cancer immunotherapy, offering a more nuanced approach.


More Pictures

VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead - e27 (Picture 1)

or

Article Details

Author / Journalist: Anisa Menur

Category: StartupsTechnology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-12 @ 02:03:20 (13 hours ago)

News Timezone: GMT +8:00

News Source URL: e27.co

Language: English

Article Length: 1122 words

Reading Time: 7 minutes read

Sentences: 1 lines

Sentence Length: 1122 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © e27

News ID: 22024301

View Article Analysis

About e27

e27 Logo

Main Topics: StartupsTechnology

Official Website: e27.co

Update Frequency: 12 posts per day

Year Established: 2006

Headquarters: Singapore

News Last Updated: 11 hours ago

Coverage Areas: Singapore

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #10

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead" has 1122 words across 1 sentences, which will take approximately 5 - 10 minutes for the average person to read.

Which news outlet covered this story?

The story "VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead" was covered 13 hours ago by e27, a news publisher based in Singapore.

How trustworthy is 'e27' news outlet?

e27 is a fully independent (privately-owned) news outlet established in 2006 that covers mostly startups and technology news.

The outlet is headquartered in Singapore and publishes an average of 12 news stories per day.

It's most recent story was published 11 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #22024301
  • URL: https://beamstart.com/news/verimmune-wants-to-help-tackle-17234306316355

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.